Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Inhibition of Human Liver Aldehyde Oxidase: Implications for Potential Drug-Drug Interactions

John T. Barr and Jeffrey P. Jones
Drug Metabolism and Disposition December 2011, 39 (12) 2381-2386; DOI: https://doi.org/10.1124/dmd.111.041806
John T. Barr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey P. Jones
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 39 no. 12 2381-2386
DOI 
https://doi.org/10.1124/dmd.111.041806
PubMed 
21940905

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 20, 2011
  • Accepted September 19, 2011
  • Published online November 21, 2011.

Article Versions

  • Earlier version (September 22, 2011 - 11:24).
  • Earlier version (September 23, 2011 - 08:03).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. John T. Barr and
  2. Jeffrey P. Jones
  1. Department of Chemistry, Washington State University, Pullman, Washington
  1. Address correspondence to:
    Dr. Jeffrey P. Jones, Department of Chemistry, Washington State University, Pullman, WA 99164. E-mail: jpj{at}wsu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2011 to January 2021

AbstractFullPdf
Sep 20113260117
Oct 2011180084
Nov 20113478140
Dec 20112911467
Jan 20121351547
Feb 20121271933
Mar 20121441727
Apr 2012821023
May 2012571113
Jun 201272821
Jul 201239314
Aug 201225109
Sep 201241413
Oct 201249725
Nov 201252315
Dec 201243717
Jan 2013562528
Feb 2013352943
Mar 201350835
Apr 201333920
May 2013451345
Jun 2013232021
Jul 201331911
Aug 2013191012
Sep 2013221815
Oct 2013252917
Nov 20138147
Dec 20137713
Jan 20146156
Feb 2014754
Mar 201427814
Apr 2014122013
May 2014151515
Jun 2014171721
Jul 201419159
Aug 20141097
Sep 2014261312
Oct 20142399
Nov 20141077
Dec 2014162210
Jan 2015251310
Feb 201511104
Mar 20151776
Apr 20151458
May 2015232113
Jun 2015191510
Jul 2015241411
Aug 201527169
Sep 201511104
Oct 2015201511
Nov 20151778
Dec 20151824
Jan 201615516
Feb 20161044
Mar 20166515
Apr 2016556
May 20161135
Jun 201611159
Jul 201614713
Aug 201630817
Sep 20166103
Oct 201692315
Nov 201662425
Dec 20163127
Jan 201761515
Feb 20173229
Mar 201741414
Apr 201742217
May 20170145
Jun 201721316
Jul 20172156
Aug 20170259
Sep 201722920
Oct 201742213
Nov 201743719
Dec 20170169
Jan 20183166
Feb 201811615
Mar 201801810
Apr 201821913
May 201801914
Jun 201812115
Jul 20180255
Aug 20182164
Sep 2018082
Oct 20182146
Nov 201811310
Dec 2018862
Jan 20191043
Feb 20191012
Mar 20191317
Apr 201920412
May 201919212
Jun 2019713
Jul 20191042
Aug 20192532
Sep 20191412
Oct 20193138
Nov 20191324
Dec 20194435
Jan 20202202
Feb 2020924
Mar 20201211
Apr 202022217
May 20201322
Jun 2020421
Jul 20201132
Aug 20202185
Sep 2020861
Oct 20202768
Nov 20201916
Dec 20201824
Jan 20211453

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 39 (12)
Drug Metabolism and Disposition
Vol. 39, Issue 12
1 Dec 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Human Liver Aldehyde Oxidase: Implications for Potential Drug-Drug Interactions
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

INHIBITION OF HUMAN LIVER AOX IN DRUG-DRUG INTERACTIONS

John T. Barr and Jeffrey P. Jones
Drug Metabolism and Disposition December 1, 2011, 39 (12) 2381-2386; DOI: https://doi.org/10.1124/dmd.111.041806

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

INHIBITION OF HUMAN LIVER AOX IN DRUG-DRUG INTERACTIONS

John T. Barr and Jeffrey P. Jones
Drug Metabolism and Disposition December 1, 2011, 39 (12) 2381-2386; DOI: https://doi.org/10.1124/dmd.111.041806
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
  • Gene expression profile of human intestinal epithelial cells
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics